The anti-angiogenesis potential of MSC Exos in the context of tumor parenchyma leads to the reduction of VEGF, inhibition of NF-κB [225], and mTOR/HIF1A/VEGF axis [226]. The gene discussed is NFKB1; the disease is neoplasm.